CRM
60
-7
VRSK
68
-12
GRMN
67
-4
ED
45
3
HSIC
45
5
GD
41
-4
NAVI
52
-2
BEN
50
9
GIS
22
-4
SNA
70
-5
JNPR
50
-6
CINF
53
3
CL
54
3
AZO
50
-5
WYNN
36
-5
MAS
52
-4
FAST
57
-3
KHC
9
-4
ADP
65
-3
CSX
57
-4
CRM
60
-7
VRSK
68
-12
GRMN
67
-4
ED
45
3
HSIC
45
5
GD
41
-4
NAVI
52
-2
BEN
50
9
GIS
22
-4
SNA
70
-5
JNPR
50
-6
CINF
53
3
CL
54
3
AZO
50
-5
WYNN
36
-5
MAS
52
-4
FAST
57
-3
KHC
9
-4
ADP
65
-3
CSX
57
-4
Financhill
Back

Capgemini SE Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
44

CGEMY
Capgemini SE

Last Price:
32.38
Seasonality Move:
5.65%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
44
Capgemini SE (CGEMY) is a Sell

Is Capgemini SE a Buy, Sell or Hold?

  • The current Capgemini SE [CGEMY] share price is $32.38. The Score for CGEMY is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • CGEMY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CGEMY Stock Price Chart

What is Capgemini SE's stock price today?

  • The Capgemini SE share price today is $32.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGEMY is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

CGEMY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.73 Sell
Relative Strength Index (14 RSI): 25.58 Sell
Chaikin Money Flow: -271869 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.3 - 39.14) Sell
Bollinger Bands (100): (37.41 - 42.47) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

CGEMY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.17 Sell
20-day SMA: 35.96 Sell
50-day SMA: 39.34 Sell
200-day SMA: 42.38 Sell
8-day EMA: 34.08 Sell
20-day EMA: 35.74 Sell
50-day EMA: 38.04 Sell
200-day EMA: 40.47 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Capgemini SE Earnings Growth & CGEMY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Capgemini SE Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):